← Open Payments lookup

AN TRAN: Open Payments

NPI 1790231801 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$501 in 20 payments from 10 companies in 2025. Trend: 2023 $603 · 2024 $798 · 2025 $501

Food & beverage: $501
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.5$162
PFIZER INC.5$124
E.R. Squibb & Sons, L.L.C.2$40
Boehringer Ingelheim Pharmaceuticals, Inc.2$37
Novo Nordisk Inc1$33
Merck Sharp & Dohme LLC1$26
Bayer Healthcare Pharmaceuticals Inc.1$25
Amgen Inc.1$24
SCPHARMACEUTICALS INC.1$15
HEARTFLOW, INC.1$15

Products named: AMVUTTRA, VYNDAQEL, CAMZYOS, JARDIANCE, Wegovy, VERQUVO, Kerendia, REPATHA.

Industry payments across CO — which companies pay providers there.